CHAPEL HILL, N.C.--(BUSINESS WIRE)--PharPoint Research, Inc., a drug development service company providing biostatistics and data management services to the pharmaceutical and biotechnology industries, launches ‘Target SAE System’, an electronic solution for the management of serious adverse events (SAE) and the integration of these data with other safety data collected in clinical trials.
